Remission of necrobiosis lipoidica diabeticorum with a JAK1/2 inhibitor: A case report

Diabetes Metab. 2021 Jul;47(4):101143. doi: 10.1016/j.diabet.2020.01.001. Epub 2020 Jan 22.

Authors

M-A Barbet-Massin¹, V Rigalleau², P Blanco², K Mohammedi², P Poupon², E Belin³, N Poursac², O Cadart², L Blanco²

Affiliations

¹ Hôpital Haut-Levêque, USN, avenue Magellan, 33604 Pessac/Bordeaux, Aquitaine, France. Electronic address: marie-amelie.barbet-massin@chu-bordeaux.fr.
² Hôpital Haut-Levêque, USN, avenue Magellan, 33604 Pessac/Bordeaux, Aquitaine, France.
³ CHU de Bordeaux, France.

PMID: 31981714
DOI: 10.1016/j.diabet.2020.01.001

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Humans
Janus Kinase 1* / antagonists & inhibitors
Janus Kinase 2* / antagonists & inhibitors
Necrobiosis Lipoidica* / drug therapy
Remission Induction

Substances

Janus Kinase 1
Janus Kinase 2